IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAVANYA ALAPATI

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1033364393
CMS profile
421332
Location
ALBANY, NY

General Payments · PY2018–2024

$1,557.53

  • Reported across 95 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$699.87

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Cardiovascular Disease NY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $699.87 50

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
NOVARTIS PHARMACEUTICALS CORPORATION $297.79 33
Boehringer Ingelheim Pharmaceuticals, Inc. $105.96 5
Merck Sharp & Dohme Corporation $78.59 4
BAXTER HEALTHCARE $57.57 1
Kiniksa Pharmaceuticals International, plc $40.51 2
PFIZER INC. $38.70 2
ABIOMED $33.80 1
Alnylam Pharmaceuticals Inc. $29.28 1
E.R. Squibb & Sons, L.L.C. $17.67 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $153.68 4
PY2019 $36.90 3
PY2020 $53.01 3
PY2021 $54.89 4
PY2022 $119.01 6
PY2023 $440.17 25
PY2024 $699.87 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $33.80 12/23/2024 Food and Beverage Undisputed 01/23/2026 1142202951 CMS
Alnylam Pharmaceuticals Inc. $29.28 09/13/2024 Food and Beverage Undisputed 01/23/2026 1125853545 CMS
Baxter Healthcare $57.57 12/23/2024 Food and Beverage Undisputed 01/23/2026 1120650729 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $19.30 02/21/2024 Food and Beverage Undisputed 01/23/2026 1117845233 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $24.19 09/17/2024 Food and Beverage Undisputed 01/23/2026 1117845237 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $27.05 10/16/2024 Food and Beverage Undisputed 01/23/2026 1117845229 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.36 11/04/2024 Food and Beverage Undisputed 01/23/2026 1117845235 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.06 11/15/2024 Food and Beverage Undisputed 01/23/2026 1117845231 CMS
E.R. Squibb & Sons, L.L.C. $17.67 06/12/2024 Food and Beverage Undisputed 01/23/2026 1101320000 CMS
Kiniksa Pharmaceuticals International, plc $21.28 06/21/2024 Food and Beverage Undisputed 01/23/2026 1154886701 CMS
Kiniksa Pharmaceuticals International, plc $19.23 10/22/2024 Food and Beverage Undisputed 01/23/2026 1154886765 CMS
Merck Sharp & Dohme LLC $22.03 01/04/2024 Food and Beverage Undisputed 01/23/2026 1141656509 CMS
Merck Sharp & Dohme LLC $16.79 05/16/2024 Food and Beverage Undisputed 01/23/2026 1141656505 CMS
Merck Sharp & Dohme LLC $19.65 10/24/2024 Food and Beverage Undisputed 01/23/2026 1141656507 CMS
Merck Sharp & Dohme LLC $20.12 11/20/2024 Food and Beverage Undisputed 01/23/2026 1141855545 CMS
Novartis Pharmaceuticals Corporation $30.30 01/10/2024 Food and Beverage Undisputed 01/23/2026 1086725953 CMS
Novartis Pharmaceuticals Corporation $3.44 01/10/2024 Food and Beverage Undisputed 01/23/2026 1086725955 CMS
Novartis Pharmaceuticals Corporation $4.04 01/19/2024 Food and Beverage Undisputed 01/23/2026 1086725909 CMS
Novartis Pharmaceuticals Corporation $13.74 01/19/2024 Food and Beverage Undisputed 01/23/2026 1086725911 CMS
Novartis Pharmaceuticals Corporation $3.22 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086725915 CMS
Novartis Pharmaceuticals Corporation $12.10 01/24/2024 Food and Beverage Undisputed 01/23/2026 1086725923 CMS
Novartis Pharmaceuticals Corporation $4.93 02/01/2024 Food and Beverage Undisputed 01/23/2026 1086725907 CMS
Novartis Pharmaceuticals Corporation $3.25 02/09/2024 Food and Beverage Undisputed 01/23/2026 1086725917 CMS
Novartis Pharmaceuticals Corporation $8.50 02/09/2024 Food and Beverage Undisputed 01/23/2026 1086725925 CMS
Novartis Pharmaceuticals Corporation $3.53 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086725919 CMS
Novartis Pharmaceuticals Corporation $2.23 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086725927 CMS
Novartis Pharmaceuticals Corporation $17.96 02/14/2024 Food and Beverage Undisputed 01/23/2026 1086725935 CMS
Novartis Pharmaceuticals Corporation $4.05 03/28/2024 Food and Beverage Undisputed 01/23/2026 1086725933 CMS
Novartis Pharmaceuticals Corporation $2.05 03/28/2024 Food and Beverage Undisputed 01/23/2026 1086725957 CMS
Novartis Pharmaceuticals Corporation $9.09 04/17/2024 Food and Beverage Undisputed 01/23/2026 1086725963 CMS
Novartis Pharmaceuticals Corporation $2.80 04/17/2024 Food and Beverage Undisputed 01/23/2026 1086725965 CMS
Novartis Pharmaceuticals Corporation $6.10 04/25/2024 Food and Beverage Undisputed 01/23/2026 1086725967 CMS
Novartis Pharmaceuticals Corporation $17.67 05/29/2024 Food and Beverage Undisputed 01/23/2026 1086725971 CMS
Novartis Pharmaceuticals Corporation $7.29 05/29/2024 Food and Beverage Undisputed 01/23/2026 1086725973 CMS
Novartis Pharmaceuticals Corporation $3.27 08/14/2024 Food and Beverage Undisputed 01/23/2026 1086725981 CMS
Novartis Pharmaceuticals Corporation $15.29 08/14/2024 Food and Beverage Undisputed 01/23/2026 1086726007 CMS
Novartis Pharmaceuticals Corporation $15.01 08/21/2024 Food and Beverage Undisputed 01/23/2026 1086726011 CMS
Novartis Pharmaceuticals Corporation $3.86 08/21/2024 Food and Beverage Undisputed 01/23/2026 1086726013 CMS
Novartis Pharmaceuticals Corporation $20.20 08/26/2024 Food and Beverage Undisputed 01/23/2026 1086725985 CMS
Novartis Pharmaceuticals Corporation $2.64 08/26/2024 Food and Beverage Undisputed 01/23/2026 1086725987 CMS
Novartis Pharmaceuticals Corporation $2.72 09/12/2024 Food and Beverage Undisputed 01/23/2026 1086726009 CMS
Novartis Pharmaceuticals Corporation $15.93 09/12/2024 Food and Beverage Undisputed 01/23/2026 1086726017 CMS
Novartis Pharmaceuticals Corporation $14.25 10/02/2024 Food and Beverage Undisputed 01/23/2026 1086726019 CMS
Novartis Pharmaceuticals Corporation $6.50 10/02/2024 Food and Beverage Undisputed 01/23/2026 1086726021 CMS
Novartis Pharmaceuticals Corporation $8.97 11/08/2024 Food and Beverage Undisputed 01/23/2026 1086726029 CMS
Novartis Pharmaceuticals Corporation $4.64 11/14/2024 Food and Beverage Undisputed 01/23/2026 1086726031 CMS
Novartis Pharmaceuticals Corporation $23.64 11/14/2024 Food and Beverage Undisputed 01/23/2026 1086726039 CMS
Novartis Pharmaceuticals Corporation $4.58 11/27/2024 Food and Beverage Undisputed 01/23/2026 1086726041 CMS
PFIZER INC. $17.97 09/27/2024 Food and Beverage Undisputed 01/23/2026 1131936958 CMS
PFIZER INC. $20.73 11/19/2024 Food and Beverage Undisputed 01/23/2026 1131097283 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.